Mannitol Intravenous Infusion BP 20% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

mannitol intravenous infusion bp 20% w/v solution for infusion

baxter healthcare limited - mannitol - solution for infusion - 20 percent weight/volume - solutions producing osmotic diuresis; mannitol

MANNITOLVIOSER SOLUTION FOR INFUSION 20 % Israel - English - Ministry of Health

mannitolvioser solution for infusion 20 %

eldan electronic instruments co ltd, israel - mannitol - solution for infusion - mannitol 200 mg/ml - mannitol - mannitol 20%, solution for infusion is indicated for: - the promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; - the reduction of intracranial pressure and treatment of cerebral edema by reducing brain mass; - the reduction of elevated intraocular pressure when the pressure cannot be lowered by other means, and promoting the urinary excretion of toxic substances

Mannitol New Zealand - English - Medsafe (Medicines Safety Authority)

mannitol

paragon care group new zealand limited t/a rem systems - mannitol 10% - solution for infusion - 10 % - active: mannitol 10%

OSMITROL Mannitol 100g/500mL injection AHB3025 Australia - English - Department of Health (Therapeutic Goods Administration)

osmitrol mannitol 100g/500ml injection ahb3025

baxter healthcare pty ltd - mannitol, quantity: 200 g/l - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - osmitrol intravenous infusion (mannitol intravenous infusion, bp) can be used in: the promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; the reduction of intraocular pressure when the pressure cannot be lowered by other means; the reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; promoting the urinary excretion of toxic substances.

Osmitrol New Zealand - English - Medsafe (Medicines Safety Authority)

osmitrol

baxter healthcare ltd - mannitol 10% - solution for infusion - 10 % - active: mannitol 10% excipient: water for injection - osmitrol intravenous infusion can be used in - the promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established;

POTASSIUM CHLORIDE  20 mmol in SODIUM CHLORIDE  0.9% 500 mL injection for intravenous infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride 20 mmol in sodium chloride 0.9% 500 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 3 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE 10 mmol in SODIUM CHLORIDE 0.9% 500 mL injection for intravenous infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride 10 mmol in sodium chloride 0.9% 500 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia